{"name":"Instituto Bernabeu","slug":"instituto-bernabeu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Gonadotrophins","genericName":"Gonadotrophins","slug":"gonadotrophins","indication":"Other","status":"marketed"},{"name":"Progesterone 200 MG","genericName":"Progesterone 200 MG","slug":"progesterone-200-mg","indication":"Other","status":"marketed"},{"name":"Urinary Human follicle stimulating hormone","genericName":"Urinary Human follicle stimulating hormone","slug":"urinary-human-follicle-stimulating-hormone","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Gonadotrophins","genericName":"Gonadotrophins","slug":"gonadotrophins","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Progesterone 200 MG","genericName":"Progesterone 200 MG","slug":"progesterone-200-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Urinary Human follicle stimulating hormone","genericName":"Urinary Human follicle stimulating hormone","slug":"urinary-human-follicle-stimulating-hormone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPVmY4SXZ2MWwtRXZBUDBQczlIVDhCUXJweFZERHJXN0RvVTRYTTM0RTZ0RC1yN2tYV2ViMG0tVlZLV0FtU20yVlRUWTczQkx4TDR4UDY0YmsyVlpIUGYyRTJjNDY5Y3pYdERKbVlrN2gzekFJUEFFaTZCTDlKM0Z4REY5Ulhtc05BMHpMcTYwNVlsZjZvR1I2ZDVVdlExSW1sNUhEMFZZd0V0THUtZWkycS1CNzRteDRsdlctSFNSOXNHdUFtYmh1YlI2cFpiU1RYdjJjcUlkWUpHaGNaQ3Eyc2xWVTVvWjl0YU8wRVIxbzQyUQ?oc=5","date":"2026-01-12","type":"pipeline","source":"investorsinhealthcare.com","summary":"Spain: Eugin becomes second-largest fertility group in Spain with acquisition of Instituto Bernabeu - investorsinhealthcare.com","headline":"Spain: Eugin becomes second-largest fertility group in Spain with acquisition of Instituto Bernabeu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBLRl92QjRiNnMtczlUa2lsbG5YUFhFUEZCVVdLR2FwaWNQaXhsOWtRaTV0OUVPdVpBQnFQYjZGaDlxb3YtWU5YY3dkekE5N2kzWHlOczBmaU9mOVhmQTM0NWNjUnNqOEcwclFKdU9YSTNSb2hHaDY2MzdUeVU?oc=5","date":"2025-12-22","type":"deal","source":"pehub.com","summary":"Buenavista portco Eugin to buy Instituto Bernabeu - pehub.com","headline":"Buenavista portco Eugin to buy Instituto Bernabeu","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}